The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Hypertrophic And Keloid Scar Treatment Market From 2026 To 2030?
The hypertrophic and keloid scar treatment market has experienced robust expansion in recent years. Its value is anticipated to increase from $8.49 billion in 2025 to $9.33 billion in 2026, displaying a compound annual growth rate (CAGR) of 9.9%. The market’s growth in previous periods can be attributed to an escalating number of surgical procedures, a greater occurrence of trauma and burns, the extensive application of corticosteroid injections, the proliferation of dermatology and cosmetic clinics, and the distinct aesthetic concerns posed by scars.
The hypertrophic and keloid scar treatment market is anticipated to experience significant expansion over the coming years. Its valuation is projected to reach $13.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. This anticipated growth is largely due to factors such as a rising inclination towards non-invasive approaches for scar treatment, the wider implementation of laser and radiotherapy methods, heightened understanding of the benefits of early scar intervention, the broadening of combined treatment strategies, and enhanced availability of sophisticated dermatological care. Key developments foreseen during this period encompass a greater acceptance of integrated scar management regimens, a surge in the need for less invasive and non-operative solutions, an expanding application of laser and energy-dependent techniques for scar revision, the development of post-operative and preventative scar care options, and a stronger emphasis on prompt action and sustained scar regulation.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Hypertrophic And Keloid Scar Treatment Market Expansion?
The hypertrophic and keloid scar treatment market is projected to grow due to an increase in road accidents and burn cases. Road accidents are defined as incidents on the road involving at least one vehicle and individuals. Both road accidents and burn cases necessitate attention and appropriate interventions for prevention and effective treatment. Hypertrophic and keloid scar treatments are applied to individuals injured in road accidents to reduce the height and tightness of scars. The rising incidence of road accidents and burn cases thus fuels the expansion of the hypertrophic and keloid scar treatment market. For instance, in January 2025, The Health Foundation, a UK-based independent organization, reported that in 2023, 43 serious or fatal casualties occurred per billion miles traveled by car, compared with 1,032 for cyclists and 1,914 for motorcyclists, while 92 pedestrians per million residents were killed or seriously injured. Consequently, the growing number of road accidents and burn cases will drive the hypertrophic and keloid scar treatment market.
What Are The Key Segment Divisions In The Hypertrophic And Keloid Scar Treatment Market Segment Structure?
The hypertrophic and keloid scar treatment market covered in this report is segmented –
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision, Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy
What Trends Are Affecting The Direction Of The Hypertrophic And Keloid Scar Treatment Market?
Companies operating in the hypertrophic and keloid scar treatment market are primarily concentrating on developing clinically validated solutions made from silicone, such as medical-grade silicone strips, to enhance their market profitability. Medical-grade silicone strips are therapeutic products crafted from superior quality silicone material, specifically formulated to promote scar recovery and reduction. For instance, in April 2023, Scar Erase, a UK-based company specializing in silicone-based scar reduction therapy, introduced Scar Erase silicone strips, which serve as a clinically tested and budget-friendly solution for scar healing. Made from 3mm of medical-grade silicone, these strips assist in the treatment of various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology effectively encapsulates the scar location, fostering hydration and an optimal healing environment, which subsequently leads to considerable improvements in scar texture, color, and height. It is designed for comfort and discretion, thus offering an accessible at-home solution for scar treatment.
Which Organizations Are Engaged In The Hypertrophic And Keloid Scar Treatment Market?
Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen
Get The Full Hypertrophic And Keloid Scar Treatment Market Report:
Which Region Holds The Highest Market Share In The Hypertrophic And Keloid Scar Treatment Market?
North America was the largest region in the hypertrophic and keloid scar treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hypertrophic And Keloid Scar Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Hypertrophic And Keloid Scar Treatment Market 2026, By The Business Research Company
Neurotrophic Keratitis Treatment Market Report 2026
Scar Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/scar-treatment-global-market-report
Keloids Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model